Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 50022966
Affinity DataIC50: 15nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 44nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 82nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 83nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 84nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 88nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 92nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 105nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 108nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 168nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 275nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 1.29E+3nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of P-gp in human K562/A02 cells over expressing P-gp assessed as reversal of multi-drug resistance by measuring ADR IC50 measured after 72...More data for this Ligand-Target Pair
